Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Aethlon Medical Inc (AEMD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7084
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company’s lead product, Hemopurifier, strengthens natural immunity in human immunodeficiency virus and hepatitis C virus infected patients. Its other pipeline products include HER2osome, for combating HER2+ breast cancer; and ELLSA exosome assay, which is an enzyme linked lectin specific assay to identify and quantify the presence of exosomes in HIV, HCV and tuberculosis. The company is also developing a medical device under the DARPA Sepsis program. Aethlon harnesses its ADAPT system to develop infrastructure of dialysis machines and CRRT systems in hospitals and clinics. Aethlon Medical is headquartered in San Diego, California, the US.

Aethlon Medical Inc (AEMD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Aethlon Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Aethlon Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Aethlon Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Aethlon Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Aethlon Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Aethlon Medical Inc, Medical Equipment, Deal Details 11
Partnerships 11
Exosome Sciences Enters into Research Agreement with Thomas Jefferson 11
Equity Offering 12
Aethlon Medical Raises USD6 Million in Public Offering of Units 12
Aethlon Medical to Raise USD2 Million in Private Placement of Shares and Warrants 13
Aethlon Medical Files Registration Statement for Public Offering of Shares for up to USD12.5 Million 14
Aethlon Medical to Raise USD6 Million in Private Placement of Shares 15
Aethlon Medical Withdraws Registration Statement for Public Offering of Shares and Warrants 16
Aethlon Medical Raises USD3.3 Million in Private Placement of Units 17
Aethlon Medical Completes Fourth Tranche Of Private Placement Of Units For US$1.8 Million 18
Exosome Sciences Completes Private Placement Shares For US$1.1 Million 19
Aethlon Medical Completes Private Placement Of Units For Additional US$0.5 Million 20
Aethlon Medical Completes Private Placement Of Units For US$0.5 Million 21
Aethlon Medical Inc – Key Competitors 22
Aethlon Medical Inc – Key Employees 23
Aethlon Medical Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 08, 2018: Aethlon Medical announces first quarter fiscal year 2019 results 25
Jun 08, 2018: Aethlon Medical Reports Fiscal 2018 Financial Results 26
Feb 01, 2018: Aethlon Medical Announces Fiscal 2018 Third Quarter Results 28
Nov 02, 2017: Aethlon Medical Announces Fiscal 2018 Second Quarter Results 30
Aug 10, 2017: Aethlon Medical Announces Fiscal 2018 First Quarter Results 31
Jun 28, 2017: Aethlon Medical Announces Fiscal 2017 Results 33
Feb 10, 2017: Aethlon Medical Announces Fiscal 2017 Third Quarter Results 35
Corporate Communications 37
Jun 25, 2018: Aethlon Medical Names Guy Cipriani As Board Director 37
Jan 10, 2018: Sabrina Martucci Johnson Joins Aethlon Medical’s Board of Directors 38
Nov 09, 2017: Dr. Charles J. Fisher, Jr. Joins Aethlon Medical’s Board of Directors 39
Government and Public Interest 40
Apr 24, 2017: Aethlon Medical Releases Shareholder Update 40
Product News 41
Jan 23, 2018: Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes 41
Mar 01, 2017: Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes 42
Other Significant Developments 43
Jan 11, 2017: Aethlon Medical Provides Clinical Study Update and a Review of 2016 Accomplishments 43
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Aethlon Medical Inc, Medical Equipment, Key Facts, 2018 2
Aethlon Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Aethlon Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Aethlon Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Aethlon Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Aethlon Medical Inc, Deals By Market, 2012 to YTD 2018 9
Aethlon Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Exosome Sciences Enters into Research Agreement with Thomas Jefferson 11
Aethlon Medical Raises USD6 Million in Public Offering of Units 12
Aethlon Medical to Raise USD2 Million in Private Placement of Shares and Warrants 13
Aethlon Medical Files Registration Statement for Public Offering of Shares for up to USD12.5 Million 14
Aethlon Medical to Raise USD6 Million in Private Placement of Shares 15
Aethlon Medical Withdraws Registration Statement for Public Offering of Shares and Warrants 16
Aethlon Medical Raises USD3.3 Million in Private Placement of Units 17
Aethlon Medical Completes Fourth Tranche Of Private Placement Of Units For US$1.8 Million 18
Exosome Sciences Completes Private Placement Shares For US$1.1 Million 19
Aethlon Medical Completes Private Placement Of Units For Additional US$0.5 Million 20
Aethlon Medical Completes Private Placement Of Units For US$0.5 Million 21
Aethlon Medical Inc, Key Competitors 22
Aethlon Medical Inc, Key Employees 23
Aethlon Medical Inc, Subsidiaries 24

List of Figures
Aethlon Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Aethlon Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Aethlon Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Aethlon Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Aethlon Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Aethlon Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Aethlon Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Aethlon Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mochida Pharmaceutical Co Ltd (4534):企業の財務・戦略的SWOT分析
    Mochida Pharmaceutical Co Ltd (4534) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • MemorialCare Health System:製薬・医療:M&Aディール及び事業提携情報
    Summary MemorialCare Health System (MemorialCare) is a non-profit health system that offers medical services. The center offers care services such as stroke care, cancer care, rehabilitation and physical therapy, weight-loss surgery, heart and vascular care, breast care, imaging and radiology, labor …
  • AgaMatrix Inc-医療機器分野:企業M&A・提携分析
    Summary AgaMatrix Inc (AgaMatrix) is a medical device company that offers biosensors. The company designs, develops and manufactures diabetes products for pharmaceutical companies. Its products include advanced blood glucose monitoring systems, and diabetes data management systems. AgaMatrix uses pr …
  • Ad Scientiam:企業の製品パイプライン分析
    Summary Ad Scientiam is a medical technology company that offers digital biomarkers which collects physiological and behavioral data. It provides mobile application which monitors patients’ behaviors and sharers the data to healthcare professionals. Ad Scientiam serves individuals, healthcare profes …
  • Societe Des Bains De Mer Sa:企業の戦略・SWOT・財務分析
    Societe Des Bains De Mer Sa - Strategy, SWOT and Corporate Finance Report Summary Societe Des Bains De Mer Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fugro NV (FUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Fugro NV (Fugro) is an integrated provider of geotechnical, survey, subsea and geosciences services. The company specializes in earth and engineering data services, from project preparation through to data acquisition, processing, analysis and interpretation, reporting and consulting. It ass …
  • iRhythm Technologies Inc (IRTC):医療機器:M&Aディール及び事業提携情報
    Summary iRhythm Technologies Inc (iRhythm) is a digital health care solutions company. It offers non-invasive long-term cardiac rhythm monitors. The company develops the Zio family of products and services to address the clinical needs of patients suffering from arrhythmias. Its product offerings in …
  • Pizza Inn, Inc:企業の戦略・SWOT・財務情報
    Pizza Inn, Inc - Strategy, SWOT and Corporate Finance Report Summary Pizza Inn, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • XOMA Corp (XOMA):企業の財務・戦略的SWOT分析
    XOMA Corp (XOMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Adira Energy Ltd (ADENF):石油・ガス:M&Aディール及び事業提携情報
    Summary Adira Energy Ltd (Adira Energy) is an oil and gas company that acquires and explores crude oil and natural gas resource properties. The company undertakes oil and gas projects across Israel. It also holds interest in three offshore petroleum projects in Yitzhak, Gabriella, and Samuel. Adira …
  • Mersen SA (MRN):企業の財務・戦略的SWOT分析
    Mersen SA (MRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Achema AB:企業の戦略的SWOT分析
    Achema AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • APEIRON Biologics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary APEIRON Biologics AG (APEIRON) is a clinical-stage biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers. The company’s pipeline products include APN01, APN301, APN311, APN401, APN411, APN421 and APN431. Its …
  • Energy XXI Gulf Coast Inc (EGC):石油・ガス:M&Aディール及び事業提携情報
    Summary Energy XXI Gulf Coast Inc (Energy XXI) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include West Delta, South Timbalier, South Pass, Main Pass, and Ship Shoal. Its West Delta property is located 28 miles offshore of Grand Isle, Louis …
  • Prospect Medical Holdings Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prospect Medical Holdings Inc (PMHI) is a healthcare service provider that offers patient care services. The center offers medical, surgical and psychiatric services, among others. It owns and operates hospitals, clinics and physician networks that offers managed care services for HMO enrole …
  • Gulf Pharmaceutical Industries PSC (JULPHAR):企業の財務・戦略的SWOT分析
    Gulf Pharmaceutical Industries PSC (JULPHAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Novartis Pharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG is a developer, manufacturer and distributor of active ingredients, patent protected medicines and treatments for the healthcare industry. The company’s products include innovative prescription medicine and drugs, tablets, …
  • Murphy Oil Corporation:戦略・SWOT・企業財務分析
    Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Anheuser-Busch Companies LLC:企業の戦略的SWOT分析
    Anheuser-Busch Companies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Babcock & Wilcox Enterprises Inc (BW):企業の財務・戦略的SWOT分析
    Babcock & Wilcox Enterprises Inc (BW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆